Received Oct 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
The diluent was given only; The diluent was given only; This non-serious case was reported by a nurse via sales rep and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis. On 17-SEP-2025, the patient received Shingrix. On 17-SEP-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: The diluent was given only) and inappropriate dose of vaccine administered (Verbatim: The diluent was given only). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK receipt date: 17-SEP-2025 The reporter reported that patient received subsequent dose of Shingrix and the diluent was given only. The reporter wanted to know the waiting period to administer the correct dose.